Indeed, several recent studies suggest that AR continues to play a key role in the survival and proliferation of HID prostate cancers via HER2 signalisation (Craft et al, 1999; Yeh et al, 1999), explaining the role of trastuzumab in the combination with docetaxel. The gene discussed is AR; the disease is prostate cancer.